Education
Master’s Degree Course in Pharmaceutical Biotechnology at School of Pharmacy, Biotechnology and Sport Science; University of Bologna, Italy. Experimental dissertation entitled “Improving gene edition tools for Wiskott-Aldrich Syndrome gene therapy”, defended on 22/10/2015.
Certificate of attendance – Use of Animals for Scientific and Educational Purposes – Level 1. University of Bologna, held on 28/01 and 4-5-11/02/2020.
Second Level Master – Pharmaceutical Technologies and Regulatory Activities at University of Torino in collaboration with Consorzio TEFARCO Innova, Associazione farmaceutici dell'industria (AFI). Held on 02/2018 – 05/2019.
Certificate of attendance – Scientific Area Security (Code ID: 101974.3). San Raffaele Hospital - reference sector ATECO 86.10.3. Held on 13/07/2016.
Certificate of attendance – Training Course On Animal Testing. San Raffaele Hospital, held on 28/11/2016, 01/12/2016 and 02/12/2016.
Research experiences
02/2018 - ongoing: Research Fellow at University of Bologna, Department of Biomedical and Neuromotor Sciences (DIBINEM). Project: "Study and in-depth research on the topic of CDKL5 deficiency disorder".
05/2016 - 07/2017: Research Fellow at IRCCS San Raffaele Scientific Institute – Diabetes Research Institute (DRI). Regulation of Adaptive Immunology Unit; Technical assistance for the analysis of lymphocytic cells in the blood and tissues of patients with diabetes and murine models. Project: “Role and therapeutic targeting of follicular helper T cells in Tipe 1 Diabetes”.
04/2014 – 12/2014: Internship at Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research (GENYO). Area of genomic medicine, Gene and Cell Therapy. Master thesis project funded by “Erasmus Placement” program of the Faculty of Pharmacy of the University of Bologna – Project: “Improving gene edition tools for Wiskott-Aldrich Syndrome gene therapy”.
Congresses
- XX Scientific Convention Telethon Foundation
Riva del Garda, 28-30/10/2019
- 18th NATIONAL CONGRESS OF THE ITALIAN SOCIETY FOR NEUROSCIENCE (SINS)
Poster: "Pharmacological targeting of the serotonergic system as a promising therapeutic approach for CDKL5 deficiency disorder (CDD)". Perugia, 26-29/09/2019. https://www.sinsmeeting.com/
- 1st International Conference on Neuroprotection by Drugs, Nutraceuticals and Physical Activity
Poster: "Loss of CDKL5 enhances microglia activation: are neuro-inflammatory mechanisms implicated in the pathophysiology of CDKL5 deficiency disorder?" Rimini Campus, Università di Bologna, 06-07/06/2019.
- OSR Retreat
Poster: "Protein tyrosine phosphatase PTPN22 controls T cell immune responses and drives viral persistence". Grand Hotel Dino, Baveno, 10-12/03/2017.
- DITID Scientific Retreat
Speaker: "Protein tyrosine phosphatase PTPN22 controls T cell immune responses and drives viral persistence". Ospedale San Raffaele, Milano, 16-17/01/2017.
- Viral Immunity Workshop
Poster: "Protein tyrosine phosphatase PTPN22 controls T cell immune responses and drives viral persistence". Centro Congressi San Raffaele, Milano, 20-21/10/2016.
- ESGCT and FSGT Collaborative Congress
Poster: "Improving gene edition tools for Wiskott-Aldrich Syndrome gene therapy". European Society of Gene and Cell Therapy, Helsinki, Finland, 09/2015.
- EMBO, Modern DNA concepts and tools for safe gene transfer and modification
Poster: "Development of a cellular reporter for WAS gene editing". Evry, France, 04/2015
- ESGCT and FSGT Collaborative Congress
Poster: "Improving gene edition tools for Wiskott-Aldrich Syndrome gene therapy". European Society of Gene and Cell Therapy, The Hague, Holland, 10/2014.
